| Argatroban | IC50 | 38.0 [1] |
| Argatroban | Ki | 19.0 [1] |
| Dabigatran | IC50 | 2.61 [1] |
| Dabigatran | Ki | 4.5 [1], 6.3 [2] |
| Efegatran | IC50 | 23.0 [1] |
| Efegatran | Ki | 5.5 [1], 7.0 [2], 10.0 [3], 18.0 [4] |
| Melagatran | IC50 | 69.2 [1] |
| Melagatran | Ki | 1.2 [1], 1.3 [2], 2.0 [3] |
| Razaxaban | Ki | 540.0 [1], 6300.0 [2] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[6-methyl-2-oxo-3-(2-phenylethylamino)pyrazin-1-yl]acetamide | IC50 | 0.8 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[6-methyl-2-oxo-3-(2-phenylethylamino)pyrazin-1-yl]acetamide | Ki | 0.8 [1] |
| (2S)-3-(7-Carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid | IC50 | 100000.0 [1], 2000000.0 [2] |
| (2S)-3-(7-Carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid | Ki | 2000.0 [1], 5000.0 [2], 2000000.0 [3] |
| 1-[n-(Naphthalen-2-Ylsulfonyl)glycyl-4-Carbamimidoyl-D-Phenylalanyl]piperidine | IC50 | 200.0 [1], 690.0 [2] |
| 1-[n-(Naphthalen-2-Ylsulfonyl)glycyl-4-Carbamimidoyl-D-Phenylalanyl]piperidine | Ki | 4.0 [1], 6.0 [2], 6.5 [3] |
| (2S)-N-[(2S)-1-(1,3-Benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | IC50 | 23.0 [1], 29.0 [2], 32.0 [3] |
| (2S)-N-[(2S)-1-(1,3-Benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 0.18 [1], 0.19 [2], 0.2 [3] |
| Sodium;[3-ethoxycarbonyl-2-[[3-ethoxycarbonyl-2-methyl-6-(2-phenylethoxy)-1-benzofuran-5-yl]oxymethyl]-6-methoxy-1-benzofuran-5-yl] sulfate | IC50 | 1600.0 [1] |
| Sodium;[6-(cyclohexylmethoxy)-3-ethoxycarbonyl-2-[(3-ethoxycarbonyl-2-methyl-6-phenylmethoxy-1-benzofuran-5-yl)oxymethyl]-1-benzofuran-5-yl] sulfate | IC50 | 2600.0 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[3-(benzylsulfonylamino)-6-methyl-2-oxopyridin-1-yl]acetamide | Ki | 0.5 [1] |
| Unii-IF979jqu3S | Ki | 0.38 [1], 0.4 [2] |
| Methyl-phe-pro-amino-cyclohexylglycine | IC50 | 6.0 [1] |
| Methyl-phe-pro-amino-cyclohexylglycine | Ki | 4.9 [1], 5.0 [2] |
| Benzamidine | Ki | 300.0 [1], 1240.0 [2], 220000.0 [3], 258000.0 [4] |
| Inogatran | IC50 | 17.0 [1], 1300.0 [2], 22400.0 [3] |
| Inogatran | Ki | 15.0 [1] |
| Acetylphenylalanyl-prolyl-boroarginine | Ki | 0.04 [1] |
| (2S)-N-[(4-Aminocyclohexyl)methyl]-1-[(2R)-2-amino-3,3-diphenylpropanoyl]pyrrolidine-2-carboxamide | IC50 | 0.1 [1] |
| (2S)-N-[(4-Aminocyclohexyl)methyl]-1-[(2R)-2-amino-3,3-diphenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 0.1 [1] |
| Thrombin Inhibitor 2 | Ki | 5.2 [1] |
| (6S,8As)-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-4-oxo-2-(3-phenylpropanoyl)-1,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-6-carboxamide | IC50 | 5.0 [1] |
| (6S,8As)-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-4-oxo-2-(3-phenylpropanoyl)-1,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-6-carboxamide | Ki | 0.6 [1] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-(1-methylimidazol-2-yl)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | IC50 | 1500.0 [1] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-(1-methylimidazol-2-yl)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 50.0 [1], 200.0 [2] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | IC50 | 19.0 [1] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 2.1 [1], 3.6 [2] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-oxo-1-pyridin-2-ylpentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | IC50 | 930.0 [1] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-oxo-1-pyridin-2-ylpentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 85.0 [1] |
| 2-[(3S)-3-(Benzylsulfonylamino)-2-oxopiperidin-1-yl]-N-[(3S)-1-carbamimidoyl-2-hydroxypiperidin-3-yl]acetamide | IC50 | 6.2 [1] |
| 2-[(3S)-3-(Benzylsulfonylamino)-2-oxopiperidin-1-yl]-N-[(3S)-1-carbamimidoyl-2-hydroxypiperidin-3-yl]acetamide | Ki | 1.0 [1] |
| 2-[(7-Carbamimidoylnaphthalen-2-yl)methyl-[4-(1-ethanimidoylpiperidin-4-yl)oxyphenyl]sulfamoyl]acetic acid | IC50 | 7.7 [1] |
| 2-[(7-Carbamimidoylnaphthalen-2-yl)methyl-[4-(1-ethanimidoylpiperidin-4-yl)oxyphenyl]sulfamoyl]acetic acid | Ki | 10000.0 [1], 100000.0 [2] |
| 2-[3-(Aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide | Ki | 6000.0 [1] |
| 4-[(Z)-[(3Z)-3-[(4-Carbamimidoylphenyl)methylidene]-2-oxocycloheptylidene]methyl]benzenecarboximidamide | Ki | 430.0 [1], 530.0 [2] |
| Cyclotheonamide A | IC50 | 23.0 [1], 1500.0 [2] |
| Cyclotheonamide A | Ki | 1.0 [1], 180.0 [2] |
| 2-(3-Carbamimidoylphenyl)-5-methyl-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide | Ki | 300.0 [1] |
| (2S)-N-[(4-Aminocyclohexyl)methyl]-1-(9-hydroxyfluorene-9-carbonyl)pyrrolidine-2-carboxamide | IC50 | 4.0 [1] |
| (2S)-N-[(4-Aminocyclohexyl)methyl]-1-(9-hydroxyfluorene-9-carbonyl)pyrrolidine-2-carboxamide | Ki | 1.5 [1] |
| 1-[[5-(5-Chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-N-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide | IC50 | 420.0 [1] |
| 1-[[5-(5-Chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-N-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide | Ki | 2760.0 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]acetamide | IC50 | 0.04 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]acetamide | Ki | 0.04 [1] |
| 4-[2-(3-Benzenesulfonylamino-phenoxy)-ethylamino]-pyridinium | Ki | 23.0 [1], 300.0 [2], 316.0 [3] |
| 2-[6-Chloro-3-[[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]amino]-2-oxopyrazin-1-yl]-N-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]acetamide | Ki | 0.0 [1] |
| (2S)-N-[(2S)-1-(1,3-Benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2S)-3-hydroxy-2-(naphthalen-1-ylsulfonylamino)propanoyl]pyrrolidine-2-carboxamide | IC50 | 110.0 [1] |
| (2S)-N-[(2S)-1-(1,3-Benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2S)-3-hydroxy-2-(naphthalen-1-ylsulfonylamino)propanoyl]pyrrolidine-2-carboxamide | Ki | 0.78 [1], 0.8 [2], 10.0 [3] |
| 2-[[(2S)-1-[(2S)-2-[(5-Carbamimidoylthiophen-2-yl)methylcarbamoyl]pyrrolidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]acetic acid | IC50 | 2.1 [1], 5.0 [2], 16.0 [3] |
| 2-[[(2S)-1-[(2S)-2-[(5-Carbamimidoylthiophen-2-yl)methylcarbamoyl]pyrrolidin-1-yl]-1-oxo-3,3-diphenylpropan-2-yl]amino]acetic acid | Ki | 0.02 [1] |
| beta-Sitosterol | IC50 | 1500000.0 [1] |
| beta-Sitosterol | Ki | 267.2 [1] |
| Betrixaban | IC50 | 10000.0 [1], 18000.0 [2] |
| 2-[3-(Aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide;hydrochloride | IC50 | 100000.0 [1] |
| 2-[3-(Aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide;hydrochloride | Ki | 6000.0 [1] |
| Wx-uk1 free base | Ki | 490.0 [1] |
| (3S)-1-Carbamimidoyl-N-[[(2S)-1-[(2S)-3-hydroxy-2-(naphthalen-2-ylsulfonylamino)propanoyl]pyrrolidin-2-yl]methyl]piperidine-3-carboxamide | IC50 | 18.0 [1] |
| (3S)-1-Carbamimidoyl-N-[[(2S)-1-[(2S)-3-hydroxy-2-(naphthalen-2-ylsulfonylamino)propanoyl]pyrrolidin-2-yl]methyl]piperidine-3-carboxamide | Ki | 3.44 [1], 3.6 [2] |
| 4-[2-(3-Benzenesulfonylamino-5-methyl-phenoxy)-ethylamino]-pyridinium | Ki | 23.0 [1], 25.0 [2] |
| 2-(2-Hydroxyphenyl)-1H-indole-5-carboxamidine | IC50 | 38000.0 [1] |
| 2-(2-Hydroxyphenyl)-1H-indole-5-carboxamidine | Ki | 13000.0 [1] |
| N-[2-(Diaminomethylideneamino)oxyethyl]-2-[6-methyl-3-[(3-methylphenyl)sulfonylamino]-2-oxopyridin-1-yl]acetamide | IC50 | 4.0 [1] |
| N-[2-(Diaminomethylideneamino)oxyethyl]-2-[6-methyl-3-[(3-methylphenyl)sulfonylamino]-2-oxopyridin-1-yl]acetamide | Ki | 4.0 [1] |
| 6-(N-Phenylcarbamyl)-2-naphthalenecarboxamidine | IC50 | 56000.0 [1] |
| 6-(N-Phenylcarbamyl)-2-naphthalenecarboxamidine | Ki | 5600.0 [1], 5640.0 [2] |
| 3-[6-(3-Carbamimidoylphenoxy)-3,5-difluoro-4-methylpyridin-2-yl]oxybenzenecarboximidamide | Ki | 22000.0 [1] |
| 2,7-Bis(4-amidinobenzylidene)cycloheptanone | Ki | 530.0 [1], 6200.0 [2] |
| 3-[[(3S)-3-[(7-Methoxynaphthalen-2-yl)sulfonylamino]-2-oxopyrrolidin-1-yl]methyl]benzenecarboximidamide | Ki | 1400.0 [1], 1430.0 [2] |
| 3-Amino-5-[1-[2-[(4-carbamimidoylphenyl)methylamino]-2-oxoethyl]-3-chloro-6-oxo-5-(propan-2-ylamino)pyrazin-2-yl]benzoic acid | IC50 | 100000.0 [1] |
| 2,6-Bis(3-amidinophenoxy)pyridine-4-carboxylic acid | Ki | 27000.0 [1] |
| 3-[6-(3-Carbamimidoyl-phenoxy)-3,5-difluoro-4-methyl-pyridin-2-yloxy]-N,N-dimethyl-benzamide | Ki | 5000.0 [1], 15000.0 [2] |
| 2-[6-Cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-oxopyrazin-1-yl]-N-[(3-fluoropyridin-2-yl)methyl]acetamide | IC50 | 2.3 [1] |
| 2-[6-Cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-oxopyrazin-1-yl]-N-[(3-fluoropyridin-2-yl)methyl]acetamide | Ki | 2.3 [1] |
| 2-Chlorobenzenesulfonic acid 3-methyl-5-(1-amidinopiperidine-4-ylmethoxy)phenyl ester | Ki | 4.6 [1] |
| (2S)-2-[[(2R)-2-(Benzylsulfonylamino)-3-phenylpropanoyl]amino]-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-3-phenylpropanamide | IC50 | 4000.0 [1] |
| (2R)-2-(Benzylsulfonylamino)-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]amino]-1-oxo-3-pyridin-3-ylpropan-2-yl]-3-phenylpropanamide | IC50 | 100000.0 [1] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-oxo-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)pentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 3.4 [1] |
| (2S)-N-[(2S)-1-(1-Benzothiophen-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 2400.0 [1] |
| (2S)-N-[(2S)-5-(Diaminomethylideneamino)-1-(1-methylbenzimidazol-2-yl)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 8.1 [1] |
| 2-[3-(Aminomethyl)phenyl]-5-methyl-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide | Ki | 6000.0 [1], 21000.0 [2] |
| N-[(4-Carbamimidoylphenyl)methyl]-2-[5-chloro-2-oxo-6-phenyl-3-(2-phenylethylamino)pyrazin-1-yl]acetamide | IC50 | 150.0 [1], 160.0 [2] |
| (S)-3-(4-Aminomethyl-phenyl)-N-cyclopentyl-N-methyl-2-(naphthalene-2-sulfonylamino)-propionamide | Ki | 18.3 [1], 50.0 [2] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]acetamide | Ki | 0.1 [1] |
| (2S)-N-[(2S)-1-(1,3-Benzoxazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | Ki | 3.8 [1], 6.2 [2] |
| (2S)-2-[[(2R)-2-(Benzylsulfonylamino)-3-phenylpropanoyl]amino]-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]butanediamide | IC50 | 60000.0 [1] |
| (2R)-2-(Benzylsulfonylamino)-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]amino]-3-(2-fluorophenyl)-1-oxopropan-2-yl]-3-phenylpropanamide | IC50 | 30000.0 [1] |
| (S)-3-(4-Carbamimidoyl-phenyl)-N-cyclopentyl-N-methyl-2-(naphthalene-2-sulfonylamino)-propionamide | Ki | 6.8 [1] |
| 2-Chlorobenzenesulfonic acid 3-methyl-5-(4-guanidinobutoxy)phenyl ester | Ki | 1.3 [1], 13.0 [2] |
| N-(3-Chloro-benzyl)-2-(6-methyl-2-oxo-3-phenylmethanesulfonylamino-2H-pyridin-1-yl)-acetamide | Ki | 7.0 [1], 7.1 [2] |
| 2-[6-Chloro-3-[[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]amino]-2-oxopyrazin-1-yl]-N-[(2-fluorophenyl)methyl]acetamide | Ki | 2.3 [1] |
| (2S)-3-(7-Carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid;hydrochloride | IC50 | 10000.0 [1] |